Brief: FDA Enters Administrative Stay Of BIDI Vapor's Marketing Denial Order For Its Flavored Ends
27/10/2021 13:15
Oct 27 (Reuters) - Kaival Brands Innovations Group Inc
KAVL.O :
* FDA ENTERS ADMINISTRATIVE STAY OF BIDI VAPOR'S MARKETING
DENIAL
ORDER FOR ITS FLAVORED ENDS
* KAIVAL BRANDS - FDA CONFIRMED THAT WHILE IT REVIEWS BIDI
VAPOR'S REQUEST, ITS FLAVORED BIDI STICKS CAN REMAIN ON MARKET
WITHOUT THREAT OF ENFORCEMENT
Source text for Eikon: ID:nPn1snBq6a
Further company coverage: KAVL.O
Recent news on Kaival Brands Innovations
See all newsCo And Delta Corp Terminate Business Combination Agreement - SEC Filing
Brief: Kaival Brands Innovations Group Inc - Enters Equity Distribution Agreement With Maxim - SEC Filing
Brief: Kaival Brands Innovations Group Inc Files For Mixed Shelf Offering Of Up To $100 Million
Brief: Delta Corp Enters Into Definitive Merger Agreement With Kaival Brands
Brief: Kaival Brands Innovations Group On Sept 16, Got Notice From Nasdaq On Co's Failure To Satisfy A Continued Listing Rule Or Standard